Shares of Oscar Health, Inc. (NYSE:OSCR – Get Free Report) have been assigned a consensus rating of “Reduce” from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. Three research analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $16.58.
A number of analysts have weighed in on the company. Raymond James Financial lowered Oscar Health from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 24th. Piper Sandler lowered their target price on Oscar Health from $25.00 to $18.00 and set an “overweight” rating for the company in a report on Monday, June 9th. Wells Fargo & Company lowered Oscar Health from an “overweight” rating to an “equal weight” rating and lowered their target price for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Barclays assumed coverage on Oscar Health in a report on Wednesday. They set an “underweight” rating and a $17.00 target price for the company. Finally, Wall Street Zen lowered Oscar Health from a “buy” rating to a “hold” rating in a report on Sunday, June 8th.
Check Out Our Latest Analysis on OSCR
Oscar Health Stock Down 0.6%
Oscar Health (NYSE:OSCR – Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.09. The company had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. Oscar Health’s revenue was up 42.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.62 earnings per share. Sell-side analysts expect that Oscar Health will post 0.69 earnings per share for the current year.
Insider Activity
In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company’s stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the transaction, the director directly owned 64,512 shares of the company’s stock, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 24.39% of the company’s stock.
Hedge Funds Weigh In On Oscar Health
Large investors have recently made changes to their positions in the business. Jones Financial Companies Lllp raised its stake in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares during the last quarter. Strs Ohio purchased a new position in Oscar Health in the 1st quarter worth $30,000. Larson Financial Group LLC raised its stake in Oscar Health by 83,733.3% in the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock worth $33,000 after acquiring an additional 2,512 shares during the last quarter. CWM LLC raised its stake in Oscar Health by 50.7% in the 1st quarter. CWM LLC now owns 3,204 shares of the company’s stock worth $42,000 after acquiring an additional 1,078 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd raised its stake in Oscar Health by 484.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company’s stock worth $45,000 after acquiring an additional 2,854 shares during the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.
About Oscar Health
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also
- Five stocks we like better than Oscar Health
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- 3 Defense Leaders Set to Gain From Rising Military Spend
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Why the Schwab Dividend ETF Rallied—and Can It Keep Climbing?
- Large Cap Stock Definition and How to Invest
- MarketBeat Week in Review – 06/30 – 07/04
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.